Mayo Clinic Talks COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

Mayo Clinic Talks

Mayo Clinic Talks Podcast #140

COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

Registration required for CME credit

 

Listen on Apple Podcast  Listen on Google Play Music  Listen on Spotify

You can also listen through your favorite podcast platform:
Apple Podcasts | Google Play Music | Stitcher | Spotify


COVID-19 information evolves daily.  The views and perspectives shared in these resources are presented based on information available at the time of recording.
Recorded March, 2020

For the most up to date information visit:
CDC - Information for Healthcare Professionals about Coronavirus (COVID-19)
World Health Organization's Country & Technical Guidance - Coronavirus disease (COVID-19)
AskMayoExpert COVID-19 Navigator
COVID-19 Online Education, Resources and Updates


Guests: Christina G. Rivera, Pharm.D., R.Ph. & Ryan W. Stevens, Pharm.D. Twitter @Stevens_AK
Hosted by: Raymund R. Razonable, M.D. Twitter @RazonableMD

Chloroquine emerged as an early COVID-19 treatment option in China and there has been increasing interest in the use of hydroxychloroquine and azithromycin. What data is available for the safety and efficacy of the drugs in the fight against SARS-CoV-2? Dr. Christina Rivera and Dr. Ryan Stevens provide a breakdown of recent research.

 

Target Audience

This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants

Learning Objectives

Upon completion of this Mayo Clinic Talks Podcast episode, learners should be able to:

  • Recall the suspected mechanism of action for hydroxychloroquine in treatment of COVID-19
  • Recall the proposed pharmacokinetics and pharmacodynamics for hydroxychloroquine in the treatment of COVID-19
  • Distinguish between the acute versus chronic effects of hydroxychloroquine use
  • Recall the impact of widespread usage of azithromycin and hydroxychloroquine for treatment of COVID-19 on the treatment of other infectious diseases

Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
Course opens: 
03/27/2020
Course expires: 
12/29/2022
Cost:
$10.00
Part of: 
Mayo Clinic Talks Podcast: COVID-19 Miniseries

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA

Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance

Price

Cost:
$10.00
Please login or register to take this course.
  1. Select the Start button. 
  2. Select the Start Course button at the bottom of the screen. 
  3. Fill out the evaluation form and claim credit. 
  4. If you need additional assistance, contact us or call our toll-free number, 1-800-323-2688.

Click here to view the online course Cancellation and Refund Policy.

Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.